Further, TPX2 siRNA inhibits tumor cell invasion and metastasis promotes tumor cell death, and could be a potential treatment option for esophageal carcinoma, medullary thyroid carcinoma, colon cancer, and breast cancer [41–44]. This evidence concerns the gene TPX2 and breast carcinoma.